MedPacto, Inc. (KOSDAQ:235980)
South Korea · Delayed Price · Currency is KRW 3,145.00
+160.00 (5.36%)
Oct 16, 2026, 3:30 PM KST
MedPacto Market Cap
MedPacto has a market cap or net worth of 107.8 billion as of October 16, 2026. It is the 26,677th most valuable company in the world and the 1,201st biggest in South Korea. Its market cap has decreased by 22.15% in one year.
Market Cap
107.80B
Enterprise Value
73.79B
Revenue
4.99B
Global Rank
Country Rank
#1,201 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 19, 2019, MedPacto's market cap has decreased from 362.50B to 107.80B, a decrease of -70.26%. That is a compound annual growth rate of -16.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 107.80B | -52.92% |
| Dec 30, 2025 | 228.96B | 50.62% |
| Dec 30, 2024 | 152.01B | -37.48% |
| Dec 28, 2023 | 243.12B | -48.17% |
| Dec 29, 2022 | 469.05B | -60.97% |
| Dec 30, 2021 | 1.20T | -49.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Cell | 201.51B |
| NeoImmuneTech | 174.11B |
| Helixmith | 171.06B |
| Anterogen.Co.,Ltd. | 145.29B |
| Genexine | 122.34B |
| Vaxcell-Bio Therapeutics | 93.73B |
| iNtRON Biotechnology | 86.03B |
| Prestige BioPharma | 67.31B |